ciprofloxacin has been researched along with mupirocin in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (7.69) | 18.2507 |
| 2000's | 8 (30.77) | 29.6817 |
| 2010's | 13 (50.00) | 24.3611 |
| 2020's | 3 (11.54) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Eldridge, GR; Garo, E; Goering, MG; Hough, GW; Hu, JF; O'Neil-Johnson, M | 1 |
| Cheung, A; Götz, F; Herbert, S; Meehl, M | 1 |
| Bryce, E; Gravel, D; Loeb, M; Louie, L; Matlow, A; McGeer, A; Mulvey, M; Ofner-Agostini, M; Simor, AE; Stuart, TL; Watt, C | 1 |
| Castanheira, M; Deshpande, LM; DiPersio, J; Jones, RN; Mendes, RE; Saubolle, MA | 1 |
| Boyd, EA; Brown, D; Collins, I; Czaplewski, LG; East, SP; Fletcher, R; Gardiner, M; Haydon, DJ; Henstock, V; Ingram, P; Jones, C; Kennison, L; Noula, C; Rockley, C; Rose, V; Stokes, NR; Thomaides-Brears, HB; Ure, R; Whittaker, M | 1 |
| Bavari, S; Bowlin, TL; Houseweart, C; Moir, DT; Opperman, TJ; Panchal, RG; Peet, NP; Williams, JD | 1 |
| Chan, JL; Cheung, GY; Joo, HS; Otto, M | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Hu, W; Lv, F; Shi, W; Xing, D; Yang, L; Yang, S; Yang, Y; Zhao, Z | 1 |
| Brozovic, A; Dowson, CG; Gazvoda, M; Košmrlj, J; Lloyd, A; Osmak, M; Proud, C; Roper, DI; Vajs, J | 1 |
| Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
| Dayal, N; Onyedibe, KI; Sintim, HO | 1 |
| Abutaleb, NS; Aryal, UK; Dieterly, A; Eldesouky, HE; Karanja, C; Liang, HW; Lyle, T; Naclerio, GA; Onyedibe, KI; Seleem, MN; Sintim, HO | 1 |
| Aldridge, KE | 1 |
| Boyce, ST; Holder, IA | 1 |
| Beeck, A; Boos, M; Fluit, AC; Hafner, D; Köhrer, K; Perdikouli, M; Scheuring, S; Schmitz, FJ; Verhoef, J; Von Eiff, C | 1 |
| Cieślikowski, T; Nowak, T; Rózalska, M; Szewczyk, EM | 1 |
| Chopra, I; Mariner, KR; O'Neill, AJ; Ooi, N; Roebuck, D | 1 |
| Anderson, M; D'Lima, L; Debabov, D; Friedman, L; Wang, L; Xu, P | 1 |
| Ahn, JW; Baek, YS; Jeon, J; Song, HJ | 1 |
| Dzięcioł, M; Giedrys-Kalemba, S; Kwiatkowski, P; Masiuk, H; Mnichowska-Polanowska, M; Pruss, A; Sienkiewicz, M | 1 |
| Albayaty, YNS; Hasan, S; Prestidge, CA; Thierry, B; Thomas, N | 1 |
| Hiramatsu, K; Hiramatsu, M; Hishinuma, T; Kirikae, T; Matsuo, M; Morimoto, Y; Sasaki, T; Singh, M; Yamamoto, N | 1 |
| Azmaiparashvili, Z; Lo, KBU | 1 |
| Hooper, DC; Reedy, JL; Truong-Bolduc, QC; Vyas, JM; Wang, Y | 1 |
26 other study(ies) available for ciprofloxacin and mupirocin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Antibacterial, partially acetylated oligorhamnosides from Cleistopholis patens.
Topics: Annonaceae; Anti-Bacterial Agents; Gabon; Glycosides; Methicillin Resistance; Molecular Structure; Plant Leaves; Plants, Medicinal; Staphylococcus aureus | 2006 |
Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacterial Proteins; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Polymyxin B; Signal Transduction; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2007 |
Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.
Topics: Aged; Anti-Bacterial Agents; Canada; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Mupirocin; Staphylococcal Infections; Staphylococcus aureus | 2007 |
First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; Drug Resistance, Bacterial; Humans; Linezolid; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Oxazolidinones; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis | 2008 |
Antibacterial alkoxybenzamide inhibitors of the essential bacterial cell division protein FtsZ.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Benzamides; Cytoskeletal Proteins; Microbial Sensitivity Tests; Staphylococcus; Structure-Activity Relationship | 2009 |
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
Topics: Bacterial Proteins; Drug Resistance, Bacterial; Indoles; Microbial Sensitivity Tests; Mutation; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus; Structure-Activity Relationship; Substrate Specificity | 2010 |
Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Cytotoxins; Methicillin-Resistant Staphylococcus aureus; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Trans-Activators; Virulence | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria.
Topics: Amidohydrolases; Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Enzyme Inhibitors; Microbial Sensitivity Tests; Molecular Structure; Oligopeptides; Structure-Activity Relationship | 2014 |
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium smegmatis; Triazenes | 2017 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
SF
Topics: | 2021 |
Mechanistic Studies and
Topics: Animals; Anti-Bacterial Agents; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Oxadiazoles; Staphylococcal Infections; Staphylococcus aureus | 2022 |
In vitro antistaphylococcal activities of two investigative fluoroquinolones, CI-960 and WIN 57273, compared with those of ciprofloxacin, mupirocin (pseudomonic acid), and peptide-class antimicrobial agents.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mupirocin; Quinolones; Staphylococcus | 1992 |
Formulation of 'idealized' topical antimicrobial mixtures for use with cultured skin grafts.
Topics: Administration, Topical; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Candida; Ciprofloxacin; Drug Combinations; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Mupirocin; Neomycin; Nystatin; Polymyxin B; Pseudomonas aeruginosa; Skin; Skin Transplantation; Staphylococcus aureus | 1996 |
Development of resistance to ciprofloxacin, rifampin, and mupirocin in methicillin-susceptible and -resistant Staphylococcus aureus isolates.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; DNA-Directed RNA Polymerases; Drug Resistance, Multiple; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Mupirocin; Rifampin; Staphylococcus aureus | 2000 |
Plasmids of Staphylococcus cohnii isolated from the intensive-care unit.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Bacteriocins; Chloramphenicol; Ciprofloxacin; Clindamycin; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Gentamicins; Hospitals, Pediatric; Intensive Care Units; Microbial Sensitivity Tests; Molecular Epidemiology; Mupirocin; Plasmids; Poland; Staphylococcus; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2004 |
Further characterization of Bacillus subtilis antibiotic biosensors and their use for antibacterial mode-of-action studies.
Topics: Amino Acyl-tRNA Synthetases; Anti-Bacterial Agents; Bacillus subtilis; Biosensing Techniques; Ciprofloxacin; Enzyme Inhibitors; Fatty Alcohols; Indoles; Mupirocin; Naphthoquinones; Oxyquinoline; Tetracyclines | 2011 |
No decrease in susceptibility to NVC-422 in multiple-passage studies with methicillin-resistant Staphylococcus aureus, S. aureus, Pseudomonas aeruginosa, and Escherichia coli.
Topics: Anti-Bacterial Agents; Bridged Bicyclo Compounds, Heterocyclic; Ciprofloxacin; Diterpenes; Drug Resistance, Multiple, Bacterial; Escherichia coli; Fusidic Acid; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Pseudomonas aeruginosa; Staphylococcus aureus; Taurine | 2012 |
Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Dibekacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fusidic Acid; Gentamicins; Humans; Infant; Infant, Newborn; Ketolides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; Oxacillin; Republic of Korea; Retrospective Studies; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Tetracycline; Vancomycin; Virginiamycin; Young Adult | 2016 |
The effect of fennel essential oil in combination with antibiotics on Staphylococcus aureus strains isolated from carriers.
Topics: Anti-Bacterial Agents; Carrier State; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Therapy, Combination; Foeniculum; Gas Chromatography-Mass Spectrometry; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Mupirocin; Oils, Volatile; Staphylococcal Infections; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination | 2017 |
Mechanistic studies of the antibiofilm activity and synergy with antibiotics of isosorbide mononitrate.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Isosorbide Dinitrate; Microbial Sensitivity Tests; Mupirocin; Nitric Oxide; Plankton; Staphylococcal Infections; Staphylococcus aureus | 2018 |
Genetic and Transcriptomic Analyses of Ciprofloxacin-Tolerant
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Gene Expression Profiling; GTP Pyrophosphokinase; Humans; Leucine-tRNA Ligase; Microbial Sensitivity Tests; Mupirocin; Staphylococcus aureus | 2019 |
Desquamating pustular rash.
Topics: Acute Generalized Exanthematous Pustulosis; Administration, Topical; Aged; Anti-Bacterial Agents; Biopsy; Ciprofloxacin; Conjunctivitis, Bacterial; Diagnosis, Differential; Drug Substitution; Emollients; Glucocorticoids; Humans; Male; Mupirocin; Ophthalmic Solutions; Skin; Treatment Outcome; Withholding Treatment | 2019 |
Staphylococcus aureus Efflux Pumps and Tolerance to Ciprofloxacin and Chlorhexidine following Induction by Mupirocin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Chlorhexidine; Ciprofloxacin; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Mupirocin; Staphylococcus aureus | 2022 |